期刊文献+

羧甲基-β-环糊精作为手性选择剂对毛细管电泳手性拆分西酞普兰的影响 被引量:5

Chiral separation of Citalopram by capillary electrophoresis with carboxymethyl-β-cyclodextrin as chiral selector
下载PDF
导出
摘要 目的以羧甲基-β-环糊精作为手性选择剂,研究西酞普兰的毛细管电泳手性拆分方法。方法选择和优化了手性选择剂的浓度、缓冲溶液的浓度、pH及分离电压等。电泳石英毛细管柱内径为75μm,总长65 cm,有效长度5 cm;紫外检测波长200 nm;柱温15℃。结果在含0.25%羧甲基-β-环糊精和25 mmol.L-1磷酸盐(pH7.0)的缓冲溶液中,分离电压为30kV时,西酞普兰对映体达到基线分离,分离度为1.6。结论所建方法可以分离分析西酞普兰对映体。 OBJECTIVE To study the chiral separation of citalopram based on capillary zone electrophoresis,with a fusedsilica capil- lary and carboxymethyl -β- cyclodrextrin as chiral selector. METHODS The effects of type and concentration of chiral selector, concentration and pH of background electrolyte, separation voltage used on the separation were investigated respectively. The separation was performed at 15 ℃ on a fused -silica capillary of 75μm × 65 em, effective length of 55 cm. The detection wavelength was 200 nm. Sample was injected into capillary at 0.5 p. s. i. for 5 s. RESULTS In the running phosphate buffer (25 mmol. L- 1 ) containing 0. 25% carboxymethyl-β- cyclodrextrin( pHT. 0),and at the applied high voltage of 30 kV,the citalopram' s enantiomers could be well separated. The resolution was 1.6. CONCLUSION The good resolution of citalopram enantiomers could be achieved under the optimal operation conditions.
出处 《华西药学杂志》 CAS CSCD 北大核心 2008年第5期594-595,共2页 West China Journal of Pharmaceutical Sciences
关键词 西酞普兰 手性拆分 毛细管电泳 羧甲基-β-环糊精 Citalopram Chiral separation Capillary electrophoresis Carboxymethyl -β- cyclodrextrin
  • 相关文献

参考文献6

二级参考文献26

  • 1史雪岩,梁沛,宋敦伦,高希武,傅若农.聚合-β环糊精作手性选择剂的毛细管电泳法分离4种光学活性农药中间体[J].分析化学,2004,32(11):1421-1425. 被引量:32
  • 2[1]Milne R J, Goa KL. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depressive illness. Drugs, 1991, 41: 450-446
  • 3[2]Baumann P, Larsen F. The pharmacokinetics of citalopram. Rev Contemp Pharmacother, 1995, 6:287-95
  • 4[3]Hyttel J, Bogeso KP, Perregaad J, et al. The pharmacological effect of citalopram residues in the (S)-(+)-enantiomers. J Neural Transm GenSect, 1992, 88:157-160
  • 5[4]Rochat R. Amey M, Baumann P. Analysis of enantiomers of citalopram and its demethylated metaholites in plasma of depressive patients using chiral reverse phase liquid chromatograhpy. Therapeutic Drug Monitoting , 1995, 17:273-279
  • 6[5]Bertilson L. Geographical/Interracial differences in polymorphic drug oxidation-Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Clin Pharmacokinet, 1995, 29:192-209
  • 7LOFTSSON T,BREWSTER M E. Pharmaceutical applications of cyclodextrins. I. Drug solubilization and stabilization[J]. Pharm Sci,1996,85,1017-1025.
  • 8BREWSTER M E, SIMPKINS J W, HORA M S,et al. The potential use of cyclodextrins in parenteral formulations [J]. Parent Sci Technol, 1989,43:231-240.
  • 9MICHAEL FERNANDEZ,MARIA L VILLALONGA,ALEX FRAGOSO,et al. a-Chymotrypsin stabilization by chemical conjugation with O-carboxymethyl-poly-β-cyclodextrin[J]. Process Biochemistry,2004,39:535-539.
  • 10TIBOR CSERHATI, ESTHER FORGACS. Effect of carboxymethyl-β-cyclodextrin on the hydrophobicity parameters of steroidal drugs[ J ]. Carbohydrate Polymers, 1999,38 : 171-177.

共引文献32

同被引文献64

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部